Development, validation and utility of an in vitro technique for assessment of potential clinical drug–drug interactions involving P-glycoprotein
- 1 April 2006
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 27 (5) , 543-554
- https://doi.org/10.1016/j.ejps.2005.11.011
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- DIFFERENTIAL INTERACTION OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE INHIBITORS WITH ABCB1, ABCC2, AND OATP1B1Drug Metabolism and Disposition, 2005
- Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteersPublished by Wiley ,2004
- THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVEDrug Metabolism and Disposition, 2003
- Effect of itraconazole on the pharmacokinetics of rosuvastatinClinical Pharmacology & Therapeutics, 2003
- Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated SecretionThe Journal of Clinical Pharmacology, 2000
- Inhibition of P-Glycoprotein–Mediated Drug TransportCirculation, 1999
- Quinidine reduces biliary clearance of digoxin in manEuropean Journal of Clinical Investigation, 1987
- INTERACTION OF DIGOXIN WITH QUININEThe Lancet, 1981
- Quinidine-Digoxin InteractionNew England Journal of Medicine, 1979
- Dose-dependence of the pharmacokinetics of quinidineEuropean Journal of Clinical Pharmacology, 1977